Epidemiology of Parkinsons
Parkinsons disease is a neurodegenerative disorder and the cause of it remained a mystery to the scientific community. Researchers says by exposing to harmful chemicals and Pesticides mutations occurs in the genes and results in neurological disorders. With age, the condition of disease increases exponentially and men are in higher proportion to prone compared to women. On an average 10million individuals are found to be suffering from Parkinson’s disease, from where only four percent of people with Parkinson’s disease are diagnosed before the age of 50. An estimated of 40% to 60% of Parkinson disease patients suffering from depression. United States stands in the fourth position in considering the death of people due to Parkinson’s disease.
- Neurodegenerative Disorders
- Gender Differences
- Age Distribution
Related Conference of Epidemiology of Parkinsons
August 16-17, 2018
3rd International Congress on Addictive Behavior & Dual Diagnosis
Stockholm, Sweden
August 27-28, 2018
8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry
Tokyo, Japan
August 31-September 01, 2018
6th World Summit on Heart, Stroke & Neurological Disorders
Heart, Stroke & Neurological Disorders
Boston, Massachusetts, USA
August 31-September 01, 2018
14th World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness
Boston, Massachusetts, USA
September 13-15, 2018
6th International Conference on Brain Disorders and Therapeutics
Copenhagen, Denmark
September 17-18, 2018
25th International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences
Dubai, UAE
September 21-22, 2018
8th International Conference on Neurology and Brain Disorders
Philadelphia, Pennsylvania, USA
September 21-22, 2018
3rd International Conference on Neuropsychiatry and Sleep Medicine
Philadelphia, Pennsylvania, USA
September 26-27, 2018
International Conference on Neuroimmunology, Neurological disorders and Neurogenetics
Montreal, Canada
September 26-27, 2018
28th World Summit on Neurology, Neuroscience and Neuropharmacology
Montreal, Quebec, Canada
October 03-04, 2018
3rd International conference on Neuroscience, Neuroradiology & Imaging
Osaka, Japan
October 18-19, 2018,
27th International Conference on Neurology and Cognitive Neuroscience
Radisson Blu Sobieski Hotel, Warsaw, Poland
October 19-20, 2018
5th International Conference on Parkinson’s disease and Movement Disorders
New York, USA
November 5-6, 2018
International Conference on Bipolar Disorder: Depression and Psychiatry
Abu Dhabi, UAE
November 12-13, 2018
4th International Conference on Central Nervous System Disorders & Therapeutics
Edinburgh, Scotland
November 12-13, 2018
30th International Conference on Mental and Behavioral Health
Melbourne, Australia
March 18-20, 2019
24th International Conference on Neurosurgery and Neuroscience
Edinburgh, Scotland
March 25-26, 2019
International Conference & Exhibition on Addictive Disorders & Addiction Therapy
Yokohama, Japan
May 08-09, 2019
5th Global Experts Meeting on Parkinsons, Huntingtons & Movement Disorders
Tokyo, Japan
June 17-18, 2019
9th International Conference on Addictive Disorders and Alcoholism
Brisbane, Australia
October 14-15, 2019
Neuroimmunology and Neuroinflammation Conference: From Discovery to Health
Dubai, UAE
October 21-22, 2019
World Congress on Advances in Brain Injury, Disorders and Therapeutics
Tokyo, Japan
Epidemiology of Parkinsons Conference Speakers
Recommended Sessions
- Pathophysiology
- Aging
- Clinical Trials in Parkinsonism
- Condition Related to Parkinsons Diseases
- Diagnosis for Parkinson’s disease
- Difficulties for Parkinson’s patients
- Difficulties for Parkinsons Patients
- Environmental toxins and Parkinson’s disease
- Environmental toxins and Parkinson’s disease
- Epidemiology of Parkinsons
- Free radicles
- Free Radicles and Aging in Parkinsons
- Huntington Disease
- Huntington’s Disease
- Innovations and Medications
- Insights and Therapeutics: Parkinson’s Disease
- Managing life with Parkinson’s Disease
- Mitochondrial Dysfunction
- Nervous system
- Neuro cognitive disorders
- Neurogenetics
- Neuroimaging
- Neuromuscular Disorders
- Neuropsychiatric
- Neuropsychiatric
- Neuropsychiatric
- Neurosurgery
- Neurosurgery
- Novel Therapeutics
- Over view of Parkinson’s disease
- Over view of Parkinson’s Disease
- Over view of Parkinson’s disease
- Parkinson Disease
- Parkinson’s disease: Complications
- Pathophysiology
- Pathophysiology and Pharmacology
- Preventions
- Risk Factors of Parkinson’s disease
Related Journals
Are you interested in
- Child and Adolescent Drug Abuse - Dual-Diagnosis 2018 (Sweden)
- Neurobiology of Addiction - Dual-Diagnosis 2018 (Sweden)
- Opioids Poisoning - Dual-Diagnosis 2018 (Sweden)
- Pharmacological Addiction - Dual-Diagnosis 2018 (Sweden)
- Addiction Nursing - Dual-Diagnosis 2018 (Sweden)
- Addiction Therapy - Dual-Diagnosis 2018 (Sweden)
- Autism Spectrum Disorder - Dual-Diagnosis 2018 (Sweden)
- Bipolar Disorders - Dual-Diagnosis 2018 (Sweden)
- Depression & Anxiety - Dual-Diagnosis 2018 (Sweden)
- Eating Disorder - Dual-Diagnosis 2018 (Sweden)
- Emotional Regulation - Dual-Diagnosis 2018 (Sweden)
- Mental Health and Substance Abuse - Dual-Diagnosis 2018 (Sweden)
- Psychoactive Drugs - Dual-Diagnosis 2018 (Sweden)
- Schizophrenia - Dual-Diagnosis 2018 (Sweden)
- Suicidal Tendency - Dual-Diagnosis 2018 (Sweden)
- Attention Deficit Hyperactivity Disorder - Dual-Diagnosis 2018 (Sweden)
- Dual Diagnosis - Dual-Diagnosis 2018 (Sweden)
- Mindfulness and Yoga - Dual-Diagnosis 2018 (Sweden)
- Neurotoxicity of Drug Abuse - Dual-Diagnosis 2018 (Sweden)
- Post Traumatical Stress Disorder (PTSD) - Dual-Diagnosis 2018 (Sweden)
- Psychotherapy and Medications - Dual-Diagnosis 2018 (Sweden)
- Rehabilitation & Recovery - Dual-Diagnosis 2018 (Sweden)